Literature DB >> 17102990

[Intracranial bleeding in acquired hemophilia].

L Marquardt1, H Haubelt, S Gass, A J Grau.   

Abstract

Acquired hemophilia is a rare complication in autoimmune disorders and malignancies. It can result in bleedings into skin and muscle, whereas intracranial hemorrhage in adults has so far not been described. We report a patient with acute intracerebral hemorrhage due to acquired hemophilia with factor VIII inhibition. The patient was treated with recombinant factor VIIa and open hematoma evacuation followed by administration of cortisone and cyclophosphamide. After good initial recovery, intracerebral rebleeding occurred and the patient died from brainstem compression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17102990     DOI: 10.1007/s00115-006-2181-0

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  12 in total

1.  Closed system endotracheal suctioning maintains lung volume during volume controlled mechanical ventilation.

Authors:  David Pogson; Peter Shirley; Elizabeth Connolly; Sharon Johnston
Journal:  Intensive Care Med       Date:  2001-11-29       Impact factor: 17.440

Review 2.  Acquired hemophilia.

Authors:  L N Boggio; D Green
Journal:  Rev Clin Exp Hematol       Date:  2001-12

3.  Long-lasting remission and successful treatment of acquired factor VIII inhibitors using cyclophosphamide in a patient with systemic lupus erythematosus.

Authors:  F Trotta; G Bajocchi; R La Corte; S Moratelli; L Y Sun
Journal:  Rheumatology (Oxford)       Date:  1999-10       Impact factor: 7.580

4.  Successful treatment of patients with rheumatic disorders and acquired factor VIII inhibitors with cyclophosphamide and prednisolone combination therapy: two case reports.

Authors:  Y Nishino; K Ueki; M Suto; H Uchiumi; F Ota; S Tamura; Y Kaneko; T Kuroiwa; Y Tsukada; A Maezawa; Y Nojima
Journal:  J Int Med Res       Date:  2001 Sep-Oct       Impact factor: 1.671

5.  Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors. Results of the novoseven emergency-use program.

Authors:  S Arkin; H A Cooper; J J Hutter; S Miller; M L Schmidt; N L Seibel; A Shapiro; I Warrier
Journal:  Haemostasis       Date:  1998 Mar-Apr

6.  Development of a factor VIII inhibitor in a newborn haemophiliac.

Authors:  S Haya; J I Lorenzo; M A Dasí; J A Aznar
Journal:  Haemophilia       Date:  1998-09       Impact factor: 4.287

Review 7.  Spontaneous intracerebral hemorrhage due to coagulation disorders.

Authors:  Alfredo Quinones-Hinojosa; Mittul Gulati; Vineeta Singh; Michael T Lawton
Journal:  Neurosurg Focus       Date:  2003-10-15       Impact factor: 4.047

8.  Acquired factor VIIIC deficiency due to circulating factor VIIIC inhibitors.

Authors:  Y K Kueh; D R Koh; T B Chan; P Han
Journal:  Ann Acad Med Singapore       Date:  1988-10       Impact factor: 2.473

9.  [Acquired haemophilia due to autoantibodies against factor VIII].

Authors:  M von Depka Prondzinski
Journal:  Hamostaseologie       Date:  2003-02       Impact factor: 1.778

10.  Severe intracranial hemorrhage in a newborn infant with transplacental transfer of an acquired factor VII:C inhibitor.

Authors:  M Ries; D Wölfel; B Maier-Brandt
Journal:  J Pediatr       Date:  1995-10       Impact factor: 4.406

View more
  1 in total

1.  Cerebellar hemorrhage as a first presentation of acquired Hemophilia A.

Authors:  Dejan Micic; Eliot C Williams; Joshua E Medow
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.